SlideShare a Scribd company logo
Breaking of the wall : role of allergy and
           histamine release


             Ronan Jambou MD, PhD

            Immunology Unit
    Institut Pasteur de Madagascar



         Vascular
       Immunology
             Unit
Expected decrease of Rural Malaria transmission

Kilifi _ Kenya Malaria J 2007
Kilifi _ Kenya Malaria J 2007   Swaziland WHO Report 2006
                                Swaziland WHO Report 2006
Changes in transmission modulate Malaria profil
                                                                                                                                                                     Total Nb of attacks 60    % within
                                                                                                                                                                           years old            adluts
                                                                                                  6
                                                                                                                   Danané, Côte d'Ivoire: ≥ 300 b.i.a./human/year             25                   10%

                                                                                                                   Dielmo, Sénégal: 100-300 b.i.a./human/year                 43                   23%
                                                                                                  5
                                                                                                                   Ndiop, Sénégal: 10-30 b.i.a./human/year                    62                   41%




                                                 A n n u a l N b o f m a l a r i a a tt a c k s
                                                                                                  4                Pikine, Sénégal: ≤1 b.i.a./human/year                      25                   50%

                                                                                                                   Saharevo, Madagascar: ≤1 b.i.a./human/year                 32                   53%

                                                                                                  3



                                                                                                  2



                                                                                                  1



                                                                                                  0
                                                                                                      0   5   10      15        20         25        30         35       40         45        50         60
                                                                                                                                       Age (years)


Kilifi _ East Africa Mwangi et al JID 2005
Kilifi _ East Africa Mwangi et al JID 2005                                                        West Africa // Madagascar (meta-analysis)
                                                                                                  West Africa Madagascar (meta-analysis)


                                     No clear change in mortality
Hunt & Grau 2003
                                Schofield & Grau 2005

sequestration   inflammation



                               pathology
                                (oedema)
Vascular permeability

                                     Histamine


                                pathogens
                                pathogens         stimuli
                                                  stimuli
Major role in:
                         EC
 Diabetes
 Diabetes
 Dengue fever
 Dengue fever
 Age degenerescence
 Age degenerescence
 ARDS
 ARDS
 Myocardial infarction
 Myocardial infarction
 Tumour angiogenesis
 Tumour angiogenesis                  Junction
                          VVO                        pinocytosis
 Brain injury
 Brain injury                       remodelling
Histamine induces vascular congestion
           Guido Majno (1961)




vein
Histamine can modulate endothelial and immune cells functions


         Allergy / helminths                 IgE         Antigen


      platelets / neutrophils                 basophiles                 HRF/TCTP



                                     Histamine

                                ( HR1, HR2, HR3, HR4, HR5 )


cytokine network (IL4, IL2..)     vascular permeability            DC response to TH2 type
    eicosanoid pathway                                                production of IgE


endothelial cells response                                                  Platelet + IRBC
    to inflammation
                                                                   vWF         adhesion
                                   Cerebral malaria ??
PfTCTP is expressed by late trophozoites
Timing genes     40
                 35                                                        gene T8h                              Pf TCTP
                 30
                                                                           gene T12h
                 25
                                                                                                         - 38% identity, 53%
                 20
                 15                                                                                      similarity with hTCTP
                 10
                      5                                                                                  - mimics hTCTP in vitro
                      0
                              P0   P6    P12     P18   P24   P30    P36    P42    P48                    on histamine release
                                                   Sampling time                                         - 0.1 to 1µg/ml in serum
                                                                                                         from patients with
                                                                                                         malaria
                  4,5
Transcript RQ




                   4
                  3,5
                                                                                                         - totally conserved in 350
   PFTCTP




                   3                                                                                     P falciparum field
                  2,5
                   2
                                                                                                         isolates => target human
                  1,5                                                                                    cells ??
                   1
                  0,5
                          2        8     14      20    26     32      38     44         50       hours
                                              Parasite cycle time                            Plasmo-DB

               - synchronisation + sampling every 6h over 54h = « sampling time »
               - use of thin smear and timing genes (P David) to define the « parasite time » (gene
               8h= MAL8P1.4, gene 12h=PFI1735c
               - normalisation of mRNA on average of (N1= PFC0255c and N2=PFA0570), then at
               time with less mRNA (T44 = 1 for PfTCTP)
Allergic response in seasonal transmission area




             « The background »
Area of Dakar




                      Gouly Couly




Seasonal                                  17°
                                            W     16°   15°   14°   13°   12°


transmission                        16°
                                      N



                                    15°
4 M inhabitants                           Dakar
= 1/3 Senegal                                           SENEGAL
                                    14°



3.5% territory                      13°




An arabiensis
Longitudinal study: Gouly couly

Enrolment                                                           End
 Jun 04                                                            Jun 06
         july 04     Nov. 04          Jun 05
           IgE      Baso, IgE        Baso, IgE


dry season     Rainy season      dry season      Rainy season   dry season


                              Drug resistance study

                                    Follow up
CD203                 CD63
    Surface marker         granule marker
activation of basophiles      Release
IgE responses : Gouly couly

                                                     100
10                                                                                                          1,5              Low
                                                      80




                                                                                             IgE ug/mL
          8
                                                                                                             1
                                                      60
          6
                                                      40                                                    0,5
          4

          2                                           20                                                     0
                                                       0                                                          july 04   Nov 04   July 05
          0
                         9-19      20-39    40-80            9-19      20-39   40-80
                                                                                                            2,5             medium
                          Total IgE ug/L                % of subjects with > 0.4µg/l                         2




                                                                                               IgE ug/mL
                                                                                                            1,5
                                                                       No difference                         1
                                nov_04                              according to age for
                    45          Jun_05                                                                      0,5
                    40
                                                                       high IgE level
                                                                                                             0
                    35
% IgE_Pf positive




                    30                                              Stability of IgE level
                    25
                                                                      « High is high »                      30
                                                                                                                             high
                    20
                                                                                                            25




                                                                                                IgE ug/mL
                    15
                                                                                                            20
                    10                                               No change in [IgE]
                    5                                                                                       15
                    0
                                                                    according to season                     10
                           9-19            20-39     40-80                                                   5
                                                                     Higher percent of                       0
                           % of subjects with IgE-Pf                                                                1         2         3
                                                                     Pf-IgE during dry
                                                                          season
Basophiles responses : Gouly couly

                                                    standard antigens
                                     nov       jun
                            90
Percent responders


                            80                                                          flmp
                            70                                                          D farinae
                            60                                                          D pteronyssinus
                            50                                                                             Percent of responders
                            40                                                                             maximum during rainy
                            30
                            20
                                                                                                                  season
                            10
                             0                                                                             Pf can induce response
                                           9-19y              20-39y         40-80y                          for 10% of villagers
                                                                                                             during rainy season
                            80        nov           jun      nov       jun    nov       jun
                                                                                                             High response for
                            70
                                                          Pf antigens                                         salivary glands
       Percent responders




                                                                                         Hemozoin
                            60
                                                                                         Pf ghost
                            50                                                           Salivary glands
                            40
                            30
                                                                                                              Mosquitoes can
                            20
                                                                                                            trigger basophiles
                            10
                                                                                                                 activation
                                 0
                                            9-19y                  20-39y           40-80y
Mosquitos bites induce mast cells activation
             JI Demeure (2005)
Basophiles responses                      IgE responses


 Percent of responders                      No difference
 maximum during rainy                    according to age for
        season                              high IgE level

 Pf can induce response                  Stability of IgE level
   for 10% of villagers                    « High is high »
   during rainy season
                                          Higher percent of
   High response for                      Pf-IgE during dry
    salivary glands                            season


    Mosquitoes can                        Anti-IgE present
  trigger basophiles                      “consummed” ?
       activation


                          Players are there !
Basophyle activation during Cerebral malaria


      « Is it a relevant question ??? »
Area of Dakar




Patients
Severe malaria (SM) cases were recruited at the Intensive Care Unit (CHNU)

Mild malaria (MM) matched cases were recruited at the Saint-Martin Dispensary

Healthy matched subjects attending the laboratory for routine examination
Basal level of CD203c expression

Mild malaria have = lower basal level of CD203c expression
IgE independant activation of basophiles




                              HZ hemozoin (malaria pigment)


Cerebral malaria = higher reactivity to IgE-independent stimulation
A




      Severe malaria
             =
    higher reactivity to
      IgE-dependent
        stimulation
B            +
    No over-stimulation
Basophiles response to anti-IgE in healthy subjects
Ex vivo priming with Pf- or h-TCTP increases IgE dependant
           response and induces over stimulation
                                       Anti-IgE 1micro/ml
                       Pf-TCTP




                         hTCTP
Basophiles response to anti-IgE in healthy subjects

                Modulation by Pf-TCTP
Pf-TCTP / anti Pf-TCTP

 Cerebral malaria = higher level of Pf-TCTP




ELISA with Pf-specific
monoclonal antibodies

                  (horizontal lines represent median for positive individuals only)
PfTCTP in serum and response to anti-IgE

                          Stimulation with anti-IgE 0 (PBS), 0.1, 1 or 10 µg/mL




Presence of PfTCTP is associated with higher IgE dependant response
Anti-PfTCTP in serum and response to IgE




Presence of anti-PfTCTP is associated with protection against
             excessive IgE dependant response
Summary


 Cerebral malaria is associated with higher basophile
  response to both IgE independent and dependant
          response, without overstimulation

rPf-TCTP enhances basophile response during CM and
      induces overstimulation in healthy subjects


Presence of PfTCTP in serum enhances IgE dependant
  response; presence of anti-Pf-TCTP decreases this
                     response.


      Allergic response is enhanced during CM
      Relevant with higher histamine detection
Histamine and brain endothelial cell interaction
          « to treat or not to treat »
Opening the junction




Histamine




                         (Vandenbrouke et al 2008)
IRBC
                                                            P < 10-6
                                    440
                                                                       NS
                                    420
                                    400
                                                 P < 10-5
                                    380
                                    360




                  Surface (pixel)
                                    340
                                    320
                                    300
                                    280
                                    260
                                    240
                                    220
                                    200
                                    180
                                          NRBC          Histamine           IRBC

Histamine 100µM
Monitoring of cells monolayer impedance to measure junction permeability
                   ECIS: Electric Cell-substrate Impedance Sensing




                                            HBEC-D3
IRBC, NRBC
                                            Histamine, TNF
                                                                      washing

                         Spreading: 5 days                    1.5 h                  24 h
HBEC


                                   Attachment and spreading of the cells              TEER
                       20000
   Resistance (ohms)




                       15000


                       10000


                        5000


                           0
                               0           20            40              60     80          100
                                                          Time (hours)
Histamine or platelet supernatant induce opening of junctions


18000                                                                                                  Control medium
Resistance
   ohm                                                                                                 Histamine
             stimulation
16000                                                                                                  LPS
                                                                                                       PLT SN
14000


12000


10000


 8000
                                       18000                                                                      Control medium
                                       Resistance
                                          ohm     Medium                                                           Histamine
                                                    change             stimulation
                                       16000                                                                       LPS
 6000                                                                                                              PLT SN
                                       14000



                                       12000


 4000                                  10000



                                        8000



 2000                                   6000



                                        4000



                                        2000                                                                    hours
    0
                                                                                                                         hours
                                           0
        29   29.5          30   30.5           23            31   28                 33   31.5   38   32   43
H1 receptor mediates histamine effect on HBECs

                0,1



               0,05



                  0

                      1   2   3   4   5   6   7   8   10   11   12   13   14   16   17    18   19   20   21   22   23   24   25

              -0,05                                                                      his100-anti_H1
ratio at T0




               -0,1                                                                      histamine100

              -0,15                                                                      TNF

               -0,2
                                                                                         hist100-antiH2

              -0,25                                                                      control

               -0,3



              -0,35

                              Anti H1 inhibits histamine effect on HBEC-D3 monolayer
Histamine induce calcium mobilization thru HR1




                                                             Normalised Ratio
             Histamine 100 µM                                                   3.6
                                                                                               Histamine
                                                                                2.6

                                                                                1.6

                                                                                0.6
                                                                                      0             20         40         60
                                                                                                      Time (min)
                 Histamine 10 µM                                                                                  Cimetidine (40µM)




                                                             Normalised Ratio
                                                                                4.6
                                                                                             Histamine
                                                                                3.6

                                                                                2.6
                                                                                                                               H2
                                                                                1.6

                                                                                0.6
                                                                                      0        20        40         60    80
                                                                                                     Time (min)
                                                                                                                  Diphenylhydramine
                                                                                                                        (20µM)
                                                                                             Histamine
                     Histamine 1 µM
          500
          400
                                                                                                                               H1
Ca (nM)




          300
          200
          100
             0
          -100
                 0        5     10       15   20   25
                                                                                          (Pre-incubation 40 min)
                                Time (min)
Histamine increases VCAM but not ICAM expression


                             18
                                                                                  Histamine 100µM, 10µM, 1µM
                             16
Percent of positive cells*



                                                                                  Cimetidine 20µM,
                             14                                                   diphenylhydramine 20µM,

                             12
                             10
                             8
                             6
                             4
                             2
                             0

                                    Histamine100 Histamine100   Histamine_10     Histamine_1            control
                                     + antiH1H2                    *Flow cytometry analysis after trypsinization of the HBEC-D3



                                  Anti H1/H2 inhibits histamine effect on VCAM1 expression
The murine model of CM

                                              Score           Observation
                                               0      No discernible clinical signs
    neurological
       phase                                   1      Hunched posture, slightly
                   hyperparasitaemia
                                                         ruffled fur

0   7              14           21
                                       days    2      Very ruffled fur, incipient
                           severe                        motor impairment
        cerebral          anaemia
        malaria                                3      Very ruffled fur, severe
                                                         motor impairment such
                                                         as ataxia, hemiplegia
        Blood collected                                  and paraplegia,
                                                         convulsions, fitting and
        Platelet-free plasma                             the Wooley white sign
                                                         (CBA only).
                                               4      Very little movement, cold
                                                         to the touch
Anti_H1 increases survival of P berghei infected mice


           100
Percent survival

                                                                      Control
                   75                                                 Citicholine
                                                                      Diphenyhydramine (anti-H1)
                   50

                   25

                   0
                        0                      7                       14
                                  Day post-PbA infection
                        Day post-PbA
                                        Control    Citicoline   DPH
                          infection
                             5.
                             6.            4                     2
                             7.            3           2         4
                             8.                        2         1
                             9.                        3
                                                                                        Beghdadi et al 2008
Conclusion

Allergy : 20% of population with high IgE level = stable
Seasonal variation of basophiles activation
=> Impact of mosquitoes bites on histamine release

Cerebral malaria is associated with hyper reactivity of
basophiles , without auto-regulation
PfTCTP enhances / anti-TCTP decrease, this response

Rapid opening of intercellular junction thru H1R
Anti-H1 can inhibit this effect

      Anti-histamine = can improve the treatment of CM ?




                         Clinical trial
University Sydney
                         V Combes
                      A Sanchez Perez
Institut Pasteur de
       Dakar             F Elassaad
    D Aldebert           MJ Jambou
                          GE. Grau         Institut Pasteur de
     S Pelleau
                                              Madagascar
    L Marrama
                                                  Romy
   F Diène-Sarr
                                                   Tsiry
       R Paul                                     Emma
   Ibrahima Dia       IMTSSA- Le Pharo
      B Diop              S Pelleau
    JC Moreau              D Parzy




                        Institut Pasteur
                              (PF5)
                       F Nato, P Beguin
Thanks for your attention
IFNg / IL10 balance

A                    B                        C




    IFNg                    IL10                    IFN/IL10
    Severe malaria = imbalanced pro/anti-inflammatory response
Histamine release and HRFs

                                           TCTP
- found in all eukaryotes , with two conserved motifs (microtubules binding domain)
- control cells proliferation, division, and apoptose => overexpression in cancer

                         Human TCTP (IgE-dependent HRF)
-Gene locus 13q12-q14
- induces histamine release by basophiles of atopic patients
- in vitro : increase reactivity of basophiles to other stimulus (IgE, ..etc)
- induce proliferation of B cells and activation of eosinophiles

                                        Pf TCTP
- 38% identity, 53% similarity with hTCTP
- mimics hTCTP in vitro on histamine release
- 0.1 to 1µg/ml in serum from patients with malaria
- totally conserved in 350 P falciparum field isolates => target human cells ??


                        Induction of idiopathic allergy ?
PfTCTP down regulates expresion of TRL2 and Vcam1 in HMEC


           60                                                  8h of stimulation
Relative
quantity
           20



           6


           2

           1



           -5



                              ICAM-1      IL-6          TNFb          TLR-2        VCAM-1
                                  IL-1b          IL-8

                Moderate direct effect of recombinant PfTCTP on endothelial cells
                 - Vcam and TRL2 repression
                 - no effect on permeability
                 - no effect on microparticules productions
sequestration
Severe Malaria




Newborn
fever
dehydration                                             Adult
convulsion                                              Respiratory distress
Metabolic disorders                                     cerebral malaria
= impaired consciousness                                low parasiteamia
                                                        = delay in treatment



                                Child
                                Severe anaemia +++
                                High parasitaemia +++
                                Cerebral pathology
From rural to urban: trends of the population

                                                                                      85             82
                                                                              76                74

              61
                                    54                      55
                                                                                           53
         47
                                                                         42
                               37                    37
    29


                          15                    17




       Monde                Afrique                  Asie                 Amérique         Régions plus
                                                                       latine/Caraïbes      avancées
                                         1950     2000           2030 (projections)

Source : Nations Unies, Perspectives de la population dans le monde, Edition 2003 (scénario moyen), 2004.
From children to adults
 0,3
                                                           0,4
                                                                                                               0-1 y
0,25                                                      0,35                                                1- 4 y
 0,2
                                                           0,3                                                5-14 y
                                                          0,25                                              15- 49 y
0,15
                                                           0,2                                                > 50 y
 0,1                                                      0,15
0,05
                                                           0,1
                                                          0,05
   0
        septembre      octobre      novembre   decembre
                                                            0
                                                                  sept         oct        nov         dec
  Prevalence of malaria in consultations
                                                                           prevalence of severe malaria.
                                                           1400
  0,6
                                                           1200
  0,5                                                      1000
  0,4                                                      800
  0,3                                                      600
  0,2                                                      400
  0,1                                                      200
   0                                                         0
        septembre octobre           novembre decembre             M        F   M     F    M      F    M      F     M     F
                                                                      0-1 an    1- 4ans    5-14 ans   15- 49 ans    50ans &+
part of class of age in the malaria cases
                                                                                consultations by age

                    Changes of risks                               Changes in control strategies

                                 Major challenge for the next 10 years
TNF plays a major role in sequestration


          sol
           or
                                                       PRBC binding
  mem     mem
  TNF      LT     ICAM-1
                  ICAM-                               monocyte binding
                upregulation
                                                              platelet binding

TNFR2
     brain endothelial cells
 Functional consequence of TNFR2 upregulation (mouse model, PbA infection)
                                        Lucas et al., Eur J Immunol 27: 1719, 1997
                               Lou, Lucas & Grau Clin Microbiol Rev 14: 810, 2001
                                      Stoelcker et al., Infect Immun 70: 5857, 2002

More Related Content

More from Institut Pasteur de Madagascar

Rapport evaluations 1an 2 ans - 2005
Rapport evaluations 1an 2 ans - 2005Rapport evaluations 1an 2 ans - 2005
Rapport evaluations 1an 2 ans - 2005
Institut Pasteur de Madagascar
 
Grille d'evalution 2005
Grille d'evalution 2005Grille d'evalution 2005
Grille d'evalution 2005
Institut Pasteur de Madagascar
 
Participants tables rondes 2005
Participants tables rondes 2005Participants tables rondes 2005
Participants tables rondes 2005
Institut Pasteur de Madagascar
 
Diaporama 2003
Diaporama 2003Diaporama 2003
Certificat 2003
Certificat 2003Certificat 2003
Grilles d'évaluations 2004
Grilles d'évaluations 2004Grilles d'évaluations 2004
Grilles d'évaluations 2004
Institut Pasteur de Madagascar
 
Synthèse des Grilles Evaluations 2003
Synthèse des Grilles Evaluations 2003Synthèse des Grilles Evaluations 2003
Synthèse des Grilles Evaluations 2003
Institut Pasteur de Madagascar
 
Guide pour le suivi et l'évaluation des programmes
Guide pour le suivi et l'évaluation des programmesGuide pour le suivi et l'évaluation des programmes
Guide pour le suivi et l'évaluation des programmes
Institut Pasteur de Madagascar
 
Monitoring and Evaluation Toolkit
Monitoring and Evaluation ToolkitMonitoring and Evaluation Toolkit
Monitoring and Evaluation Toolkit
Institut Pasteur de Madagascar
 
Développement nouveaux médicaments
Développement nouveaux médicamentsDéveloppement nouveaux médicaments
Développement nouveaux médicaments
Institut Pasteur de Madagascar
 
Diagnostic biologique du paludisme
Diagnostic biologique du paludismeDiagnostic biologique du paludisme
Diagnostic biologique du paludisme
Institut Pasteur de Madagascar
 
Guide d’élaboration d’un plan de gestion des achats et des stocks (Global Fun...
Guide d’élaboration d’un plan de gestion des achats et des stocks (Global Fun...Guide d’élaboration d’un plan de gestion des achats et des stocks (Global Fun...
Guide d’élaboration d’un plan de gestion des achats et des stocks (Global Fun...
Institut Pasteur de Madagascar
 
Guide d’élaboration d’un plan de gestion des achats et des stocks (Global Fun...
Guide d’élaboration d’un plan de gestion des achats et des stocks (Global Fun...Guide d’élaboration d’un plan de gestion des achats et des stocks (Global Fun...
Guide d’élaboration d’un plan de gestion des achats et des stocks (Global Fun...
Institut Pasteur de Madagascar
 
PharmacoVigilance & Supply
PharmacoVigilance & SupplyPharmacoVigilance & Supply
PharmacoVigilance & Supply
Institut Pasteur de Madagascar
 
Guide d’élaboration d’un plan de gestion des achats et des stocks (Global Fun...
Guide d’élaboration d’un plan de gestion des achats et des stocks (Global Fun...Guide d’élaboration d’un plan de gestion des achats et des stocks (Global Fun...
Guide d’élaboration d’un plan de gestion des achats et des stocks (Global Fun...
Institut Pasteur de Madagascar
 
Réponse immunitaite et anémie sévère
Réponse immunitaite et anémie sévèreRéponse immunitaite et anémie sévère
Réponse immunitaite et anémie sévère
Institut Pasteur de Madagascar
 
Pharmacopée traditionnelle et paludisme
Pharmacopée traditionnelle et paludismePharmacopée traditionnelle et paludisme
Pharmacopée traditionnelle et paludisme
Institut Pasteur de Madagascar
 
Les suivis de cohorte dans l’étude du paludisme : place dans les études épidé...
Les suivis de cohorte dans l’étude du paludisme : place dans les études épidé...Les suivis de cohorte dans l’étude du paludisme : place dans les études épidé...
Les suivis de cohorte dans l’étude du paludisme : place dans les études épidé...
Institut Pasteur de Madagascar
 
Polymorphisme parasitaire et accès graves en zone périurbaine
Polymorphisme parasitaire et accès graves en zone périurbainePolymorphisme parasitaire et accès graves en zone périurbaine
Polymorphisme parasitaire et accès graves en zone périurbaine
Institut Pasteur de Madagascar
 

More from Institut Pasteur de Madagascar (20)

Rapport evaluations 1an 2 ans - 2005
Rapport evaluations 1an 2 ans - 2005Rapport evaluations 1an 2 ans - 2005
Rapport evaluations 1an 2 ans - 2005
 
Synthese 2005
Synthese 2005Synthese 2005
Synthese 2005
 
Grille d'evalution 2005
Grille d'evalution 2005Grille d'evalution 2005
Grille d'evalution 2005
 
Participants tables rondes 2005
Participants tables rondes 2005Participants tables rondes 2005
Participants tables rondes 2005
 
Diaporama 2003
Diaporama 2003Diaporama 2003
Diaporama 2003
 
Certificat 2003
Certificat 2003Certificat 2003
Certificat 2003
 
Grilles d'évaluations 2004
Grilles d'évaluations 2004Grilles d'évaluations 2004
Grilles d'évaluations 2004
 
Synthèse des Grilles Evaluations 2003
Synthèse des Grilles Evaluations 2003Synthèse des Grilles Evaluations 2003
Synthèse des Grilles Evaluations 2003
 
Guide pour le suivi et l'évaluation des programmes
Guide pour le suivi et l'évaluation des programmesGuide pour le suivi et l'évaluation des programmes
Guide pour le suivi et l'évaluation des programmes
 
Monitoring and Evaluation Toolkit
Monitoring and Evaluation ToolkitMonitoring and Evaluation Toolkit
Monitoring and Evaluation Toolkit
 
Développement nouveaux médicaments
Développement nouveaux médicamentsDéveloppement nouveaux médicaments
Développement nouveaux médicaments
 
Diagnostic biologique du paludisme
Diagnostic biologique du paludismeDiagnostic biologique du paludisme
Diagnostic biologique du paludisme
 
Guide d’élaboration d’un plan de gestion des achats et des stocks (Global Fun...
Guide d’élaboration d’un plan de gestion des achats et des stocks (Global Fun...Guide d’élaboration d’un plan de gestion des achats et des stocks (Global Fun...
Guide d’élaboration d’un plan de gestion des achats et des stocks (Global Fun...
 
Guide d’élaboration d’un plan de gestion des achats et des stocks (Global Fun...
Guide d’élaboration d’un plan de gestion des achats et des stocks (Global Fun...Guide d’élaboration d’un plan de gestion des achats et des stocks (Global Fun...
Guide d’élaboration d’un plan de gestion des achats et des stocks (Global Fun...
 
PharmacoVigilance & Supply
PharmacoVigilance & SupplyPharmacoVigilance & Supply
PharmacoVigilance & Supply
 
Guide d’élaboration d’un plan de gestion des achats et des stocks (Global Fun...
Guide d’élaboration d’un plan de gestion des achats et des stocks (Global Fun...Guide d’élaboration d’un plan de gestion des achats et des stocks (Global Fun...
Guide d’élaboration d’un plan de gestion des achats et des stocks (Global Fun...
 
Réponse immunitaite et anémie sévère
Réponse immunitaite et anémie sévèreRéponse immunitaite et anémie sévère
Réponse immunitaite et anémie sévère
 
Pharmacopée traditionnelle et paludisme
Pharmacopée traditionnelle et paludismePharmacopée traditionnelle et paludisme
Pharmacopée traditionnelle et paludisme
 
Les suivis de cohorte dans l’étude du paludisme : place dans les études épidé...
Les suivis de cohorte dans l’étude du paludisme : place dans les études épidé...Les suivis de cohorte dans l’étude du paludisme : place dans les études épidé...
Les suivis de cohorte dans l’étude du paludisme : place dans les études épidé...
 
Polymorphisme parasitaire et accès graves en zone périurbaine
Polymorphisme parasitaire et accès graves en zone périurbainePolymorphisme parasitaire et accès graves en zone périurbaine
Polymorphisme parasitaire et accès graves en zone périurbaine
 

Recently uploaded

Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
jval Landero
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 

Recently uploaded (20)

Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 

Breaking of the wall : role of allergy and histamine release

  • 1. Breaking of the wall : role of allergy and histamine release Ronan Jambou MD, PhD Immunology Unit Institut Pasteur de Madagascar Vascular Immunology Unit
  • 2. Expected decrease of Rural Malaria transmission Kilifi _ Kenya Malaria J 2007 Kilifi _ Kenya Malaria J 2007 Swaziland WHO Report 2006 Swaziland WHO Report 2006
  • 3. Changes in transmission modulate Malaria profil Total Nb of attacks 60 % within years old adluts 6 Danané, Côte d'Ivoire: ≥ 300 b.i.a./human/year 25 10% Dielmo, Sénégal: 100-300 b.i.a./human/year 43 23% 5 Ndiop, Sénégal: 10-30 b.i.a./human/year 62 41% A n n u a l N b o f m a l a r i a a tt a c k s 4 Pikine, Sénégal: ≤1 b.i.a./human/year 25 50% Saharevo, Madagascar: ≤1 b.i.a./human/year 32 53% 3 2 1 0 0 5 10 15 20 25 30 35 40 45 50 60 Age (years) Kilifi _ East Africa Mwangi et al JID 2005 Kilifi _ East Africa Mwangi et al JID 2005 West Africa // Madagascar (meta-analysis) West Africa Madagascar (meta-analysis) No clear change in mortality
  • 4. Hunt & Grau 2003 Schofield & Grau 2005 sequestration inflammation pathology (oedema)
  • 5. Vascular permeability Histamine pathogens pathogens stimuli stimuli Major role in: EC Diabetes Diabetes Dengue fever Dengue fever Age degenerescence Age degenerescence ARDS ARDS Myocardial infarction Myocardial infarction Tumour angiogenesis Tumour angiogenesis Junction VVO pinocytosis Brain injury Brain injury remodelling
  • 6. Histamine induces vascular congestion Guido Majno (1961) vein
  • 7. Histamine can modulate endothelial and immune cells functions Allergy / helminths IgE Antigen platelets / neutrophils basophiles HRF/TCTP Histamine ( HR1, HR2, HR3, HR4, HR5 ) cytokine network (IL4, IL2..) vascular permeability DC response to TH2 type eicosanoid pathway production of IgE endothelial cells response Platelet + IRBC to inflammation vWF adhesion Cerebral malaria ??
  • 8. PfTCTP is expressed by late trophozoites Timing genes 40 35 gene T8h Pf TCTP 30 gene T12h 25 - 38% identity, 53% 20 15 similarity with hTCTP 10 5 - mimics hTCTP in vitro 0 P0 P6 P12 P18 P24 P30 P36 P42 P48 on histamine release Sampling time - 0.1 to 1µg/ml in serum from patients with malaria 4,5 Transcript RQ 4 3,5 - totally conserved in 350 PFTCTP 3 P falciparum field 2,5 2 isolates => target human 1,5 cells ?? 1 0,5 2 8 14 20 26 32 38 44 50 hours Parasite cycle time Plasmo-DB - synchronisation + sampling every 6h over 54h = « sampling time » - use of thin smear and timing genes (P David) to define the « parasite time » (gene 8h= MAL8P1.4, gene 12h=PFI1735c - normalisation of mRNA on average of (N1= PFC0255c and N2=PFA0570), then at time with less mRNA (T44 = 1 for PfTCTP)
  • 9. Allergic response in seasonal transmission area « The background »
  • 10. Area of Dakar Gouly Couly Seasonal 17° W 16° 15° 14° 13° 12° transmission 16° N 15° 4 M inhabitants Dakar = 1/3 Senegal SENEGAL 14° 3.5% territory 13° An arabiensis
  • 11. Longitudinal study: Gouly couly Enrolment End Jun 04 Jun 06 july 04 Nov. 04 Jun 05 IgE Baso, IgE Baso, IgE dry season Rainy season dry season Rainy season dry season Drug resistance study Follow up
  • 12. CD203 CD63 Surface marker granule marker activation of basophiles Release
  • 13. IgE responses : Gouly couly 100 10 1,5 Low 80 IgE ug/mL 8 1 60 6 40 0,5 4 2 20 0 0 july 04 Nov 04 July 05 0 9-19 20-39 40-80 9-19 20-39 40-80 2,5 medium Total IgE ug/L % of subjects with > 0.4µg/l 2 IgE ug/mL 1,5 No difference 1 nov_04 according to age for 45 Jun_05 0,5 40 high IgE level 0 35 % IgE_Pf positive 30 Stability of IgE level 25 « High is high » 30 high 20 25 IgE ug/mL 15 20 10 No change in [IgE] 5 15 0 according to season 10 9-19 20-39 40-80 5 Higher percent of 0 % of subjects with IgE-Pf 1 2 3 Pf-IgE during dry season
  • 14. Basophiles responses : Gouly couly standard antigens nov jun 90 Percent responders 80 flmp 70 D farinae 60 D pteronyssinus 50 Percent of responders 40 maximum during rainy 30 20 season 10 0 Pf can induce response 9-19y 20-39y 40-80y for 10% of villagers during rainy season 80 nov jun nov jun nov jun High response for 70 Pf antigens salivary glands Percent responders Hemozoin 60 Pf ghost 50 Salivary glands 40 30 Mosquitoes can 20 trigger basophiles 10 activation 0 9-19y 20-39y 40-80y
  • 15. Mosquitos bites induce mast cells activation JI Demeure (2005)
  • 16. Basophiles responses IgE responses Percent of responders No difference maximum during rainy according to age for season high IgE level Pf can induce response Stability of IgE level for 10% of villagers « High is high » during rainy season Higher percent of High response for Pf-IgE during dry salivary glands season Mosquitoes can Anti-IgE present trigger basophiles “consummed” ? activation Players are there !
  • 17. Basophyle activation during Cerebral malaria « Is it a relevant question ??? »
  • 18. Area of Dakar Patients Severe malaria (SM) cases were recruited at the Intensive Care Unit (CHNU) Mild malaria (MM) matched cases were recruited at the Saint-Martin Dispensary Healthy matched subjects attending the laboratory for routine examination
  • 19. Basal level of CD203c expression Mild malaria have = lower basal level of CD203c expression
  • 20. IgE independant activation of basophiles HZ hemozoin (malaria pigment) Cerebral malaria = higher reactivity to IgE-independent stimulation
  • 21. A Severe malaria = higher reactivity to IgE-dependent stimulation B + No over-stimulation
  • 22. Basophiles response to anti-IgE in healthy subjects
  • 23. Ex vivo priming with Pf- or h-TCTP increases IgE dependant response and induces over stimulation Anti-IgE 1micro/ml Pf-TCTP hTCTP
  • 24. Basophiles response to anti-IgE in healthy subjects Modulation by Pf-TCTP
  • 25. Pf-TCTP / anti Pf-TCTP Cerebral malaria = higher level of Pf-TCTP ELISA with Pf-specific monoclonal antibodies (horizontal lines represent median for positive individuals only)
  • 26. PfTCTP in serum and response to anti-IgE Stimulation with anti-IgE 0 (PBS), 0.1, 1 or 10 µg/mL Presence of PfTCTP is associated with higher IgE dependant response
  • 27. Anti-PfTCTP in serum and response to IgE Presence of anti-PfTCTP is associated with protection against excessive IgE dependant response
  • 28. Summary Cerebral malaria is associated with higher basophile response to both IgE independent and dependant response, without overstimulation rPf-TCTP enhances basophile response during CM and induces overstimulation in healthy subjects Presence of PfTCTP in serum enhances IgE dependant response; presence of anti-Pf-TCTP decreases this response. Allergic response is enhanced during CM Relevant with higher histamine detection
  • 29. Histamine and brain endothelial cell interaction « to treat or not to treat »
  • 30. Opening the junction Histamine (Vandenbrouke et al 2008)
  • 31. IRBC P < 10-6 440 NS 420 400 P < 10-5 380 360 Surface (pixel) 340 320 300 280 260 240 220 200 180 NRBC Histamine IRBC Histamine 100µM
  • 32. Monitoring of cells monolayer impedance to measure junction permeability ECIS: Electric Cell-substrate Impedance Sensing HBEC-D3
  • 33. IRBC, NRBC Histamine, TNF washing Spreading: 5 days 1.5 h 24 h HBEC Attachment and spreading of the cells TEER 20000 Resistance (ohms) 15000 10000 5000 0 0 20 40 60 80 100 Time (hours)
  • 34. Histamine or platelet supernatant induce opening of junctions 18000 Control medium Resistance ohm Histamine stimulation 16000 LPS PLT SN 14000 12000 10000 8000 18000 Control medium Resistance ohm Medium Histamine change stimulation 16000 LPS 6000 PLT SN 14000 12000 4000 10000 8000 2000 6000 4000 2000 hours 0 hours 0 29 29.5 30 30.5 23 31 28 33 31.5 38 32 43
  • 35. H1 receptor mediates histamine effect on HBECs 0,1 0,05 0 1 2 3 4 5 6 7 8 10 11 12 13 14 16 17 18 19 20 21 22 23 24 25 -0,05 his100-anti_H1 ratio at T0 -0,1 histamine100 -0,15 TNF -0,2 hist100-antiH2 -0,25 control -0,3 -0,35 Anti H1 inhibits histamine effect on HBEC-D3 monolayer
  • 36. Histamine induce calcium mobilization thru HR1 Normalised Ratio Histamine 100 µM 3.6 Histamine 2.6 1.6 0.6 0 20 40 60 Time (min) Histamine 10 µM Cimetidine (40µM) Normalised Ratio 4.6 Histamine 3.6 2.6 H2 1.6 0.6 0 20 40 60 80 Time (min) Diphenylhydramine (20µM) Histamine Histamine 1 µM 500 400 H1 Ca (nM) 300 200 100 0 -100 0 5 10 15 20 25 (Pre-incubation 40 min) Time (min)
  • 37. Histamine increases VCAM but not ICAM expression 18 Histamine 100µM, 10µM, 1µM 16 Percent of positive cells* Cimetidine 20µM, 14 diphenylhydramine 20µM, 12 10 8 6 4 2 0 Histamine100 Histamine100 Histamine_10 Histamine_1 control + antiH1H2 *Flow cytometry analysis after trypsinization of the HBEC-D3 Anti H1/H2 inhibits histamine effect on VCAM1 expression
  • 38. The murine model of CM Score Observation 0 No discernible clinical signs neurological phase 1 Hunched posture, slightly hyperparasitaemia ruffled fur 0 7 14 21 days 2 Very ruffled fur, incipient severe motor impairment cerebral anaemia malaria 3 Very ruffled fur, severe motor impairment such as ataxia, hemiplegia Blood collected and paraplegia, convulsions, fitting and Platelet-free plasma the Wooley white sign (CBA only). 4 Very little movement, cold to the touch
  • 39. Anti_H1 increases survival of P berghei infected mice 100 Percent survival Control 75 Citicholine Diphenyhydramine (anti-H1) 50 25 0 0 7 14 Day post-PbA infection Day post-PbA Control Citicoline DPH infection 5. 6. 4 2 7. 3 2 4 8. 2 1 9. 3 Beghdadi et al 2008
  • 40. Conclusion Allergy : 20% of population with high IgE level = stable Seasonal variation of basophiles activation => Impact of mosquitoes bites on histamine release Cerebral malaria is associated with hyper reactivity of basophiles , without auto-regulation PfTCTP enhances / anti-TCTP decrease, this response Rapid opening of intercellular junction thru H1R Anti-H1 can inhibit this effect Anti-histamine = can improve the treatment of CM ? Clinical trial
  • 41. University Sydney V Combes A Sanchez Perez Institut Pasteur de Dakar F Elassaad D Aldebert MJ Jambou GE. Grau Institut Pasteur de S Pelleau Madagascar L Marrama Romy F Diène-Sarr Tsiry R Paul Emma Ibrahima Dia IMTSSA- Le Pharo B Diop S Pelleau JC Moreau D Parzy Institut Pasteur (PF5) F Nato, P Beguin
  • 42. Thanks for your attention
  • 43. IFNg / IL10 balance A B C IFNg IL10 IFN/IL10 Severe malaria = imbalanced pro/anti-inflammatory response
  • 44. Histamine release and HRFs TCTP - found in all eukaryotes , with two conserved motifs (microtubules binding domain) - control cells proliferation, division, and apoptose => overexpression in cancer Human TCTP (IgE-dependent HRF) -Gene locus 13q12-q14 - induces histamine release by basophiles of atopic patients - in vitro : increase reactivity of basophiles to other stimulus (IgE, ..etc) - induce proliferation of B cells and activation of eosinophiles Pf TCTP - 38% identity, 53% similarity with hTCTP - mimics hTCTP in vitro on histamine release - 0.1 to 1µg/ml in serum from patients with malaria - totally conserved in 350 P falciparum field isolates => target human cells ?? Induction of idiopathic allergy ?
  • 45. PfTCTP down regulates expresion of TRL2 and Vcam1 in HMEC 60 8h of stimulation Relative quantity 20 6 2 1 -5 ICAM-1 IL-6 TNFb TLR-2 VCAM-1 IL-1b IL-8 Moderate direct effect of recombinant PfTCTP on endothelial cells - Vcam and TRL2 repression - no effect on permeability - no effect on microparticules productions
  • 47. Severe Malaria Newborn fever dehydration Adult convulsion Respiratory distress Metabolic disorders cerebral malaria = impaired consciousness low parasiteamia = delay in treatment Child Severe anaemia +++ High parasitaemia +++ Cerebral pathology
  • 48. From rural to urban: trends of the population 85 82 76 74 61 54 55 53 47 42 37 37 29 15 17 Monde Afrique Asie Amérique Régions plus latine/Caraïbes avancées 1950 2000 2030 (projections) Source : Nations Unies, Perspectives de la population dans le monde, Edition 2003 (scénario moyen), 2004.
  • 49. From children to adults 0,3 0,4 0-1 y 0,25 0,35 1- 4 y 0,2 0,3 5-14 y 0,25 15- 49 y 0,15 0,2 > 50 y 0,1 0,15 0,05 0,1 0,05 0 septembre octobre novembre decembre 0 sept oct nov dec Prevalence of malaria in consultations prevalence of severe malaria. 1400 0,6 1200 0,5 1000 0,4 800 0,3 600 0,2 400 0,1 200 0 0 septembre octobre novembre decembre M F M F M F M F M F 0-1 an 1- 4ans 5-14 ans 15- 49 ans 50ans &+ part of class of age in the malaria cases consultations by age Changes of risks Changes in control strategies Major challenge for the next 10 years
  • 50. TNF plays a major role in sequestration sol or PRBC binding mem mem TNF LT ICAM-1 ICAM- monocyte binding upregulation platelet binding TNFR2 brain endothelial cells Functional consequence of TNFR2 upregulation (mouse model, PbA infection) Lucas et al., Eur J Immunol 27: 1719, 1997 Lou, Lucas & Grau Clin Microbiol Rev 14: 810, 2001 Stoelcker et al., Infect Immun 70: 5857, 2002